Concepedia

John Friend

JF

Statistics

Publications

14

Citations

1.7K

H-Index

14

Active since

1954

Affiliations

Helsinn Therapeutics (United States)(Current)

Massachusetts General Hospital

Duke University

University of California, San Francisco

Flinders University

John Friend is an author at Helsinn Therapeutics (United States) specializing in medicine, oncology, and cachexia management.

Publications per year

1954–2022

14

Publications

14

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

Jennifer S. Temel, Amy P. Abernethy, David C. Currow et al. · The Lancet Oncology · 2016 · 628 citations

, , +12

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials

José M. Garcia, Ralph V. Boccia, Charles D. Graham et al. · The Lancet Oncology · 2014 · 216 citations

, , +7

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

David C. Currow, Jennifer S. Temel, Amy P. Abernethy et al. · Annals of Oncology · 2017 · 179 citations · Full text

, , +16

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study

José M. Garcia, John Friend, Suzan Allen · Supportive Care in Cancer · 2012 · 168 citations

, , +12

Blood flow in pulmonary veins: I Studies in dog and man

B. Rajagopalan, John Friend, T. J. Stallard et al. · Cardiovascular Research · 1979 · 120 citations

, , +16

1–5 of 14